"You wake up every day and faced with a new problem in Pakistan cricket. We now have to revise all our plans for the coming events," Rasheed told PTI.
Meanwhile, a spokesman in the Pakistan Cricket Board made it clear that since ICC was dealing with the Yasir case under the anti-doping regulations, there would be no comments on the issue.
"As per ICC rules, a process would be followed now but at this time all we know is that he is provisionally banned and is most probably out of the tour to New Zealand," he said.
"Yasir apparently took some medicines for a blood pressure problem but didn't inform the team doctor or the PCB medical panel, which was a grave mistake," the source said.
He revealed that the PCB Chairman Shaharyar Khan was also upset with the team management for not keeping a closer watch on what medicines the players use for ailments.
Interestingly, the ban on Yasir now makes it easier for the selectors to justify recalling tainted left-arm pacer Muhammad Aamir for the tour to New Zealand.
Yasir, 29, has been Pakistan's mainstay in Test matches since last year, scalping 76 wickets in 12 matches to lead the ICC bowler rankings. He has also picked up 18 ODI wickets.
In the past, Pakistan fast bowlers Shoaib Akhtar and Muhammad Asif had tested positive for banned substances and were subsequently suspended from the 2006 Champions Trophy and 2007 World Cup.
The ICC said in a release that Yasir had tested positive in a random test taken on November 13 for Chlortalidone, a prohibited substance.
"It is a big blow and in just one year's time we have lost three of our best spinners in Saeed Ajmal, Muhammad Hafeez and Yasir. But only Pakistan cricket has the capacity to recover from this setback," he said.
He said that Aamir's return to the national side was now a mere formality.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
